Wuxi Biologics has reported a full-year net income of 3.40 billion yuan, falling short of the estimated 3.58 billion yuan. The company’s revenue exceeded estimates, coming in at 17.03 billion yuan against an estimated 16.98 billion yuan. Adjusted net income surpassed estimates, with Wuxi Biologics reporting 4.70 billion yuan against an estimated 4.2 billion yuan. The gross margin for the c...
$藥明康德(02359.HK)$closed up by 5.7% and$藥明生物(02269.HK)$rose by 7.5% in Hong Kong on Monday after the departure of Mike Gallagher, chairman of the House Select Committee on the Chinese Communist Party, which could slow the legislation’s progress of the Biosecure Act. $恒生中國企業(02828.HK)$$恒生指數(800000.HK)$
Peter YCS樓主 : 我在美國市場買入,香港這專業割投資人韭菜……美國市場可能少量買入在看它是否跌落在哪……香港一手就要500股一手,太狠了,不如投藥明康德,一手100股,還有股息……
Gancongyap : 需要小心這股票... 因為美國大球員會禁止這股票... 由於人類基因... 美國類似禁止華為
103115047 : 無知是很可怕的
總有一天等到你 : 有提到還可以買嗎
trend investor : 今天又新低了
查看更多評論...